⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 15, 2024Open Access

Supplementary Figure S2 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

B7-H4 cell surface expression in cell lines and B7-H4-ADC cytotoxicity.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gitto et al. (2024) studied this question.

synapsesocial.com/papers/68e6f2a2b6db64358766d239 https://doi.org/10.1158/1078-0432.25603638

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S2 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression2024
2Supplementary Figure S5 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression2024
3Supplementary Figure S5 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression2024
4Supplementary Figure S8 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression2024
5Supplementary Figure S8 from A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression2024